Chirasmita Nayak

Dihydroactinidiolide, a natural product against Aβ25-35 induced toxicity in Neuro2a cells: Synthesis, in silico and in vitro studies

Mamali Das, Sengodu Prakash, Chirasmita Nayak et al. · Bioorganic Chemistry · 2018 · 42 citations

Medicine, Neuroscience, Pharmacology +17

Integrated Transcriptome Profiling Identifies Prognostic Hub Genes as Therapeutic Targets of Glioblastoma: Evidenced by Bioinformatics Analysis

Chirasmita Nayak, Sanjeev Kumar Singh · ACS Omega · 2022 · 24 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Deep insights into the mode of ATP-binding mechanism in Zebrafish cyclin-dependent protein kinase-like 1 (zCDKL1): A molecular dynamics approach

Ajaya Kumar Rout, Budheswar Dehury, Jitendra Maharana et al. · Journal of Molecular Graphics and Modelling · 2018 · 20 citations

Life Sciences, Biochemistry, Molecular Biology +14

An <i>in silico</i> pharmacological approach toward the discovery of potent inhibitors to combat drug resistance HIV‐1 protease variants

Chirasmita Nayak, Ishwar Chandra, Sanjeev Kumar Singh · Journal of Cellular Biochemistry · 2018 · 19 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

In silico identification of natural product inhibitors against Octamer-binding transcription factor 4 (Oct4) to impede the mechanism of glioma stem cells

Chirasmita Nayak, Sanjeev Kumar Singh · PLoS ONE · 2021 · 18 citations · Full text

Medicine, Oncology, Pharmacology +17